After securing quick OK for PNH patients, Alexion's Ultomiris succeeds in aHUS pivotal study
About a month after the FDA gave Alexion a Christmas present in the form of an early approval for its rare blood disorder drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
